ANP32E: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS (v470) |
||
Line 1: | Line 1: | ||
< | {{Infobox_gene}} | ||
{{ | '''Acidic leucine-rich nuclear phosphoprotein 32 family member E''' is a [[protein]] that in humans is encoded by the ''ANP32E'' [[gene]].<ref name="pmid12438741">{{cite journal |vauthors=Jiang M, Ma Y, Ni X, Cao G, Ji C, Cheng H, Tang R, Xie Y, Mao Y | title = Molecular cloning and characterization of a novel human gene (ANP32E alias LANPL) from human fetal brain | journal = Cytogenet Genome Res | volume = 97 | issue = 1–2 | pages = 68–71 |date=Nov 2002 | pmid = 12438741 | pmc = | doi =10.1159/000064058 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: ANP32E acidic (leucine-rich) nuclear phosphoprotein 32 family, member E| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=81611| accessdate = }}</ref> The ANP32E gene is located on chromosome 1q22.<ref name="pmid12438741" /> In mammalian cells, ANP32E has been shown to be an [[H2AFZ | H2A.Z]] chaperone capable of promoting the removal of H2A.Z from chromatin.<ref name="pmid24463511">{{cite journal |vauthors=Obri A, Ouararhni K, Papin C, Diebold ML, Padmanabhan K, Marek M, Stoll I, Roy L, Reilly PT, Mak TW, Dimitrov S, Romier C, Hamiche A | title = ANP32E is a histone chaperone that removes H2A.Z from chromatin | journal = Nature | volume = 505 | issue = 7485 | pages = 648–53 | year = 2014 | pmid = 24463511 | doi = 10.1038/nature12922 }}</ref> In brain tissue, ANP32E together with Cpd1 regulate protein phosphatase 2A activity at synapses during synaptogenesis<ref name="pmid16420440">{{cite journal |vauthors=Costanzo RV, Vilá-Ortíz GJ, Perandones C, Carminatti H, Matilla A, Radrizzani M | title = Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis | journal = Eur. J. Neurosci. | volume = 23 | issue = 2 | pages = 309–24 | year = 2006 | pmid = 16420440 | doi = 10.1111/j.1460-9568.2005.04555.x }}</ref> and has been observed to form a complex with ANP32A and SET that stabilizes short-lived mRNAs containing AU-rich elements, as well as having acetyltransferase inhibitory activity (in a complex with SET) and having a role in chromatin remodeling and transcriptional regulation.<ref name="pmid14964690">{{cite journal | author = Santa-Coloma TA | title = Anp32e (Cpd1) and related protein phosphatase 2 inhibitors | journal = Cerebellum | volume = 2 | issue = 4 | pages = 310–20 | year = 2003 | pmid = 14964690 | doi = 10.1080/14734220310017212 }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
==See also== | |||
* [[ANP32A]], [[ANP32B]], [[ANP32C]], [[ANP32D]] | |||
==References== | |||
{{ | {{reflist}} | ||
| | ==External links== | ||
}} | * {{UCSC gene info|ANP32E}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal |vauthors=Matilla A, Radrizzani M |title=The Anp32 family of proteins containing leucine-rich repeats |journal=Cerebellum |volume=4 |issue= 1 |pages= 7–18 |year= 2005 |pmid= 15895553 |doi=10.1080/14734220410019020 }} | |||
*{{cite journal |vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} | |||
*{{cite journal | | *{{cite journal |vauthors=Hartley JL, Temple GF, Brasch MA |title=DNA cloning using in vitro site-specific recombination |journal=Genome Res. |volume=10 |issue= 11 |pages= 1788–95 |year= 2001 |pmid= 11076863 |doi=10.1101/gr.143000 | pmc=310948 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M | title = Nucleolar proteome dynamics | journal = Nature | volume = 433 | issue = 7021 | pages = 77–83 | year = 2005 | pmid = 15635413 | doi = 10.1038/nature03207 }} | ||
*{{cite journal | | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
{{gene-1-stub}} | |||
{{ | |||
Latest revision as of 03:20, 27 October 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Acidic leucine-rich nuclear phosphoprotein 32 family member E is a protein that in humans is encoded by the ANP32E gene.[1][2] The ANP32E gene is located on chromosome 1q22.[1] In mammalian cells, ANP32E has been shown to be an H2A.Z chaperone capable of promoting the removal of H2A.Z from chromatin.[3] In brain tissue, ANP32E together with Cpd1 regulate protein phosphatase 2A activity at synapses during synaptogenesis[4] and has been observed to form a complex with ANP32A and SET that stabilizes short-lived mRNAs containing AU-rich elements, as well as having acetyltransferase inhibitory activity (in a complex with SET) and having a role in chromatin remodeling and transcriptional regulation.[5]
See also
References
- ↑ 1.0 1.1 Jiang M, Ma Y, Ni X, Cao G, Ji C, Cheng H, Tang R, Xie Y, Mao Y (Nov 2002). "Molecular cloning and characterization of a novel human gene (ANP32E alias LANPL) from human fetal brain". Cytogenet Genome Res. 97 (1–2): 68–71. doi:10.1159/000064058. PMID 12438741.
- ↑ "Entrez Gene: ANP32E acidic (leucine-rich) nuclear phosphoprotein 32 family, member E".
- ↑ Obri A, Ouararhni K, Papin C, Diebold ML, Padmanabhan K, Marek M, Stoll I, Roy L, Reilly PT, Mak TW, Dimitrov S, Romier C, Hamiche A (2014). "ANP32E is a histone chaperone that removes H2A.Z from chromatin". Nature. 505 (7485): 648–53. doi:10.1038/nature12922. PMID 24463511.
- ↑ Costanzo RV, Vilá-Ortíz GJ, Perandones C, Carminatti H, Matilla A, Radrizzani M (2006). "Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis". Eur. J. Neurosci. 23 (2): 309–24. doi:10.1111/j.1460-9568.2005.04555.x. PMID 16420440.
- ↑ Santa-Coloma TA (2003). "Anp32e (Cpd1) and related protein phosphatase 2 inhibitors". Cerebellum. 2 (4): 310–20. doi:10.1080/14734220310017212. PMID 14964690.
External links
- Human ANP32E genome location and ANP32E gene details page in the UCSC Genome Browser.
Further reading
- Matilla A, Radrizzani M (2005). "The Anp32 family of proteins containing leucine-rich repeats". Cerebellum. 4 (1): 7–18. doi:10.1080/14734220410019020. PMID 15895553.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Hartley JL, Temple GF, Brasch MA (2001). "DNA cloning using in vitro site-specific recombination". Genome Res. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.
- Andersen JS, Lam YW, Leung AK, Ong SE, Lyon CE, Lamond AI, Mann M (2005). "Nucleolar proteome dynamics". Nature. 433 (7021): 77–83. doi:10.1038/nature03207. PMID 15635413.
This article on a gene on human chromosome 1 is a stub. You can help Wikipedia by expanding it. |